Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab

enthalten in: Cancers | 2022

von Wu, Y. | Fulgenzi, C. | D'Alessio, A. | +32

HG-05DIFFERENTIAL EXPRESSION OF PARP1/2 AS A BIOMARKER OF DIPG MALIGNANT PROGRESSION: RELATIONSHIP TO TGF-β/BMP SIGNALING AND EZH2 GLOBAL METHYLATION

enthalten in: Neuro-Oncology | 2016

von Maachani, U. | Shankavaram, U. | Schweitzer, M. | +3

Abstract 1367: Intra-cerebral pharmacokinetic monitoring of a tyrosine kinase inhibitor (theranostic 18[F]-PET/NIRF labeled dasatinib) delivered via convection-enhanced delivery

enthalten in: Cancer research | 2016

von Wang, M. | Zhou, Z. | Kommidi, H. | +6